Gynoguard VT Vaginal Tablet 10 mg is an antiseptic and antimicrobial agent used primarily in the treatment of throat infections and other oral conditions. It is a quaternary ammonium compound with broad-spectrum activity against bacteria, fungi, and some viruses.
Gynoguard VT Vaginal Tablet 10 mg is used for:
| Brand Name | Gynoguard VT |
|---|---|
| Type | Vaginal Tablet |
| Weight | 10 mg |
| Generic | Dequalinium Chloride |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Gynoguard VT Vaginal Tablet 10 mg acts by disrupting the cell membrane integrity of microorganisms, leading to cell death. Its quaternary ammonium structure allows it to interact with the bacterial cell membrane, altering its permeability and causing leakage of essential cellular components.
The onset of action for Gynoguard VT Vaginal Tablet 10 mg can vary, but improvements in symptoms may be noticed within a few days of starting treatment. The time to full therapeutic effect depends on the severity of the infection and individual patient response.
When used topically or as a lozenge, Gynoguard VT Vaginal Tablet 10 mg has minimal systemic absorption. Its action is primarily localized to the area of application.
Gynoguard VT Vaginal Tablet 10 mg is not significantly absorbed into the bloodstream when used topically, so it is primarily eliminated through the local mucosal surfaces. Any small amounts that are absorbed are likely excreted in the urine.
The dosage of Gynoguard VT Vaginal Tablet 10 mg depends on the specific formulation and the condition being treated:
Gynoguard VT Vaginal Tablet 10 mg is administered topically or as lozenges. Lozenges should be allowed to dissolve slowly in the mouth without chewing. For topical solutions or gels, apply as directed to the affected area.
Common side effects may include:
Toxicity is unlikely with topical or oral use as directed. However, ingestion of large amounts or inappropriate use can lead to gastrointestinal distress, including nausea and vomiting. In case of suspected overdose, seek medical attention.
Precautions include:
Gynoguard VT Vaginal Tablet 10 mg may interact with other topical or oral medications, potentially altering their effectiveness or increasing the risk of side effects. Inform your healthcare provider of all medications and treatments being used.
Use with caution in patients with:
Drug interactions are generally minimal with topical Gynoguard VT Vaginal Tablet 10 mg. However, potential interactions with other oral or topical treatments should be evaluated to avoid possible antagonistic effects.
There are no significant food interactions reported with Gynoguard VT Vaginal Tablet 10 mg. However, it is recommended to avoid eating or drinking immediately after the application of topical treatments or lozenges to ensure optimal effectiveness.
Gynoguard VT Vaginal Tablet 10 mg is classified as a Category C drug during pregnancy. It should be used during pregnancy only if clearly needed and if the benefits outweigh the risks. Consult a healthcare provider for advice if pregnant or planning to become pregnant.
Gynoguard VT Vaginal Tablet 10 mg is unlikely to affect breastfeeding when used topically or as lozenges. However, consult a healthcare provider for personalized advice if breastfeeding, especially if using the medication in significant amounts or over extended periods.
Acute overdose is unlikely with topical or lozenge forms. If excessive amounts are ingested, gastrointestinal symptoms such as nausea and vomiting may occur. Seek medical attention for management of symptoms and supportive care.
Contraindications include:
Follow the dosage instructions provided by a healthcare provider or on the product label. Lozenges should be allowed to dissolve slowly in the mouth, and topical solutions or gels should be applied to the affected area as directed.
Store Gynoguard VT Vaginal Tablet 10 mg at room temperature, away from direct sunlight and moisture. Keep the product in its original container with the lid tightly closed. Store out of reach of children.
The volume of distribution for Gynoguard VT Vaginal Tablet 10 mg is primarily localized to the mucosal surfaces where it is applied. Systemic distribution is minimal due to limited absorption from topical use.
The half-life of Gynoguard VT Vaginal Tablet 10 mg is not well-documented due to its minimal systemic absorption. Its primary effect is localized to the application area, where it remains active for several hours.
Gynoguard VT Vaginal Tablet 10 mg is primarily cleared locally from the site of application. Any small amounts that are absorbed into the bloodstream are excreted via the kidneys. The exact clearance rate is not well-documented due to its limited systemic absorption.
See in details version Gynoguard VT Vaginal Tablet 10 mg also Gynoguard VT Vaginal Tablet 10 mg in bangla